4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

8.56

-0.05 (-0.58%)

At close: Mar 18, 2026, 4:00 PM EDT

8.70

+0.14 (1.64%)

After-hours: Mar 18, 2026, 4:38 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Biotechnology	37.00K	20.72M	3.13M	18.04M	13.61M
Biotechnology Growth	-99.82%	562.29%	-82.65%	32.52%	94.85%
Total	37.00K	20.72M	3.13M	18.04M	13.61M
Total Growth	-99.82%	562.29%	-82.65%	32.52%	94.85%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	37.00K	20.16M	35.00K	121.00K	-27.00K
United States Growth	-99.82%	57488.57%	-71.07%	-	-
Netherlands	-	567.00K	3.09M	736.00K	742.00K
Netherlands Growth	-	-81.67%	320.38%	-0.81%	2753.85%
Switzerland	-	-	-	17.18M	12.90M
Switzerland Growth	-	-	-	33.22%	105.14%
Total	37.00K	20.72M	3.13M	18.04M	13.61M
Total Growth	-99.82%	562.29%	-82.65%	32.52%	94.85%

Source: S&P Global Market Intelligence.